Injective ETF applications advance in US
Injective (INJ)
Editor:
Eugene Serbin
1millionbacklinks.com reports that momentum is building for Injective ETFs as two US applications advance. These advancing applications could enhance INJ's market presence. The move has the potential to influence broader crypto investment trends. It may also shape the regulatory landscapes for the asset.
How the market reacted
Whalio's own Binance spot order flow for INJ, measured when this story was written up on 6 October 2026. Not the outlet's figures.
INJ trades at $7.68 with a 1-hour buy ratio of 55.4% and a 4-hour ratio of 54.9%, both exceeding the 24-hour reading of 50.6%. This indicates that buying pressure is currently building relative to the longer daily trend. Positive volume deltas of $29,769 (1h) and $306,944 (4h) show that buy volume is currently outweighing sell volume in the short term. The 24-hour Cumulative Volume Delta stands at +$529,399, confirming net buying over the full day. Buyers have been in control for 15 of the last 24 hours.
The latest daily buy ratio of 53.4% sits at the 91st percentile of the last 322 days, against a median of 49.8% - among the strongest buying days it has had.
Was that an ordinary day?
The same Binance spot measurements for INJ, averaged over the days leading up to the story.
Over the preceding week, the average buy ratio was 48.8%, making today's 24-hour ratio of 50.6% an unusual day with 1.8 points of excess buying. Spot volume of $8,011,306 is 0.72x the weekly average, indicating lower trading activity than usual. Net buying occurred on 4 of the last 7 days, contrasting with a total 8-day volume delta of -$1,367,613. The price rose 3.6% over the 8-day period despite the negative aggregate delta.